https://www.statnews.com/2025/10/30/eli-lilly-zepbound-mounjaro-bestselling-obesity-drug/
Oct 30, 2025 - The therapy, marketed as Zepbound and Mounjaro, took the crown from Merck's blockbuster cancer drug at a striking pace.
weight lossdiabetes drugelitopskeytruda
https://endpoints.news/keluns-trop2-adc-plus-keytruda-improves-outcomes-in-first-line-lung-cancer/
Nov 24, 2025 - Kelun-Biotech reports Phase 3 success for sac-TMT/Keytruda combo in lung cancer, beating Keytruda alone in PD-L1-positive NSCLC patients. Data headed to...
adcpluskeytrudaoutcomes
https://www.statnews.com/2025/02/04/merck-gardasil-keytruda-cancer-drug-china/
Feb 4, 2025 - The cancer drug will lose its patent exclusivity in 2028. And it could face lower reimbursement from Medicare under the Inflation Reduction Act before that.
earningsmissfocusedattentionreal
https://www.pharmavoice.com/news/keytruda-merck-cancer-lung-long-term-results/633087/
Long-term results showed five-year survival numbers for lung cancer patients that surpassed all others, and Merck's VP of oncology research tells us...
keytrudagiftkeepsgivingmerck
https://www.biopharmadive.com/news/merck-keytruda-breast-cancer-roche-tecentriq/572198/
When added to chemo, Merck's immunotherapy kept a difficult-to-treat form of breast cancer from progressing, provided patients had an important...
breast cancermerckbuildscasekeytruda
https://www.biopharmadive.com/news/keytruda-fda-approval-perioperative-adjuvant-neoadjuvant-lung-cancer/696790/
The Merck drug leads competitors Opdivo and Imfinzi into a new immunotherapy setting, which aims to improve outcomes following the surgical removal of tumors.
keytrudagainsfirstapprovalpre
https://www.prnewswire.com/news-releases/halozyme-wins-preliminary-injunction-against-mercks-keytruda-sc-in-germany-302633457.html
/PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) (Halozyme), announced today that a German court has granted its request for a preliminary...
winspreliminarymerckkeytrudasc
https://www.medicalnewstoday.com/articles/keytruda
Aug 21, 2025 - Keytruda is a brand-name infusion approved to treat several types of cancer. Learn about side effects, warnings, dosage, and more.
side effectskeytrudausescost